Neopentylamine Market Overview
The Neopentylamine
Market size is projected to grow at a CAGR of 5.1% during the forecast period 2022-2027 and reach US$2.1 billion by 2027. Neopentylamine is a primary amine
derivative of neopentane and it is also known as 1-amino-2, 2-dimethylpropane
or 2,2-dimethylpropylamine. It is mainly used in the pharmaceutical and
chemical industries. The expansion of the Neopentylamine Market is primarily driven
by its usage in the pharmaceutical industry. In 2020, the onset of the
COVID-19 pandemic led to strict lockdowns all over the world, which interrupted
the entire supply and trade of raw materials from manufacturing hubs. This, in
turn, resulted in slow developments and manufacturing in the pharmaceutical
sector, thus, temporarily affecting the growth of the global neopentylamine industry.
However, a steady recovery in pharmaceutical production has been witnessed
since 2021, which is driving the demand for neopentylamine. According to the Brazilian Chemical Industry Association, the
production of the pharmaceutical industry in Brazil was valued at US$16.1
billion in 2021, an increase of 2.6% from US$15.7 billion in 2020. An increase
in pharmaceutical production along with the growth of the chemical industry is
expected to drive the growth of the Neopentylamine Market size in the upcoming
years. On the other hand, health hazards associated
with the use of Neopentylamine may confine the growth of the market.
Neopentylamine Market Report Coverage
The
"Neopentylamine Market Report – Forecast (2022-2027)” by IndustryARC,
covers an in-depth analysis of the following segments in the global Neopentylamine Market.
Key Takeaways
- More than 97% purity segment held a
significant share in the Neopentylamine Market in 2021. Its
wide range of characteristics along with its higher physical and chemical
properties made it stand out in comparison to other types of synthesis methods
in the market.
- The Pharmaceutical industry held the largest share in the Neopentylamine Market in 2021. The
anti-inflammatory properties of Neopentylamine make them ideal for use as
pharmaceutical intermediates utilized in the industry.
- Asia-Pacific dominated the Neopentylamine Market in 2021, owing to the increasing demand for Neopentylamine from the pharmaceutical sector in the region.
- A detailed analysis of strengths, weaknesses, opportunities and threats would be provided in the Neopentylamine Market Report.
Figure: Neopentylamine Market Share, By Geography, 2021 (%)
For More Details On this report - Request For Sample
Neopentylamine Market Segment Analysis – by Purity
More than 97% purity segment held a share of over 20% in the Neopentylamine Market in 2021. This is fueled by the increasing demand for neopentylamine due to the benefits it offers over other types of purity. For instance, higher-purity neopentylamine of more than 97% has very low impurities and allows manufacturers to make mass production as well as active pharmaceutical ingredients. Moreover, higher-purity neopentylamine of more than 97% helps in creating precise and distinct pharmaceutical and chemical formulations as compared to other types of lower-purity neopentylamine. Furthermore, high-purity neopentylamine of more than 97% has higher chemical and physical properties that are ideal for use in the pharmaceutical and chemical sectors. Hence, all of these properties are driving its demand over other types of purity, which in turn, is expected to boost the market growth during the forecast period.
Neopentylamine Market Segment Analysis – by End-use Industry
The pharmaceutical
industry held the largest share of over 25% in the Neopentylamine Market in
2021, owing to the
increasing production from pharmaceutical sectors across the world. According to the European Federation of Pharmaceutical Industries and
Associations (EFPIA), the total production of pharmaceuticals including
capsules, tablets and other products in Europe was valued at EUR 310,000
million (approx. US$354,080.76 million) in 2020. Moreover, according to the
Government of Japan Ministry of Health, the total pharmaceutical production in
Japan reached US$84.6 million in 2020.
Neopentylamine (also known as 1-amino-2, 2-dimethylpropane or 2,2-dimethylpropylamine) is a primary amine derivative of neopentane. Due to its anti-inflammatory properties, it is primarily used as a pharmaceutical intermediate or active pharmaceutical ingredient utilized during the production of pharmaceutical drugs and medicines. Thus, such surging production from the pharmaceutical sector across the world is expected to increase the demand for neopentylamine. This is expected to expand the Neopentylamine Market size during the forecast period.
Neopentylamine Market Segment Analysis – by Geography
Asia-Pacific dominated the Neopentylamine Market with a 35% share in 2021. The consumption of neopentylamine is particularly high in this region due to its increasing demand from the pharmaceutical sector. According to the General Statistics Office of Vietnam, the total pharmaceutical production in Vietnam was valued at US$3484.5 million in 2020, an increase of around 7% from US$3255.6 million in 2019. According to Vietnam’s Ministry of Health, the pharmaceutical industry is expected to grow at a rate of 10% per year from 2017 to 2028. This is due to an increase in pharmaceutical production and sales in the country. Furthermore, according to India Brand Equity Foundation (IBEF), India ranked 3rd in terms of pharmaceutical production by volume in 2021. It further states that the domestic pharmaceutical industry in India includes around 3,000 drug companies and approx. 10,500 manufacturing units. This is expected to accelerate market growth during the forecast period.
Neopentylamine Market Drivers
An increase in pharmaceutical production:
Neopentylamine (also known as 1-amino-2,
2-dimethylpropane or 2,2-dimethylpropylamine) is a primary
amine derivative of neopentane. It is primarily used
as a pharmaceutical intermediate or active pharmaceutical ingredient utilized
during
the production of pharmaceutical drugs and medicines. The
anti-inflammatory properties of neopentylamine make it ideal for use in such
pharmaceutical applications. According to the Government of Japan
Ministry of Health, Labor and Welfare (MHLW), the production of pharmaceuticals
in Japan was valued at US$87.03 million in 2019, an increase of 39% in
comparison to the previous year. Moreover, recent insights from the
International Trade Administration state that the total consumption of
pharmaceutical products in Mexico reached up to US$11.1 billion in 2020,
representing an increase of 2.8% from US$10.8 billion in 2019. Hence, such an
increase in pharmaceutical production is expected to increase the demand for neopentylamine, owing to its above-mentioned properties
and usage. This is anticipated to drive
the growth of the market in the upcoming years.
Growth of the chemical industry:
Neopentylamine is
commonly utilized in the chemical industry for use in chemical reagents needed
for various types of chemical analysis, during the preparation and production
of chemicals. According to
the American Chemistry Council, Inc., the production of industrial chemicals
increased significantly by 5.9% in 2021 as compared to 2020. It further states
that the total production from the chemical industry in the U.S. is expected to
increase by up to 4.3% in 2022. Furthermore,
according to the European Chemical Industry Council, the total chemical sales
in Europe accounted for 18.1% of global chemical sales in 2020. Similarly,
Asia, excluding China, Japan and South Korea, accounted for 15.4%, while Latin
America accounted for 2.7% of the global sales in 2020. Hence, such surging
growth of the global chemical industry is expected to increase the demand for Neopentylamine
for use in chemical reagents during the preparation and
production of chemicals.
Neopentylamine Market Challenges
Health hazards associated with the use of Neopentylamine:
Neopentylamine
is considered to be hazardous by the 2012
OSHA Hazard Communication Standard (29 CFR 1910.1200). Its contact with acids releases very toxic gas. Furthermore, inhalation
of vapors or fumes generated by the material during the course of normal
handling may produce severely toxic effects which may be fatal. In case of contact
with the eye, it may cause eye irritation or serious eye damage in acute cases.
In addition to this, severe cough, headache, nausea and shortness of breath are
some of the common symptoms associated with prolonged exposure to
neopentylamine. In severe cases, it may cause skin corrosion, organ toxicity
and failure of the respiratory system. Thus, such health hazards associated with
the use of neopentylamine
may limit the growth of the global Neopentylamine Industry during the forecast
period.
Neopentylamine Industry Outlook
Technology launches,
acquisitions and increased R&D activities are key strategies adopted by players
in the Neopentylamine Market. The top
companies in the Neopentylamine Market are:
- TCI Chemicals
- Alfa Chemistry
- 3B Scientific Corporation
- Apollo Scientific
- City Chemicals
- VWR International
- ChongQing Purel Bio-Pharmaceutical Technology
- J & K Scientific
- Beijing Ouhe Technology
- Shanghai Longsheng Chemical
Relevant Reports
Report Code: CMR
87791
Report Code: CMR
0276
Report Code: CMR 0277
For more Chemicals and Materials Market reports, please click here
LIST OF TABLES
1.Global Neopentylamine Market, by Type Market 2023-2030 ($M)2.Global Neopentylamine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
3.Global Neopentylamine Market, by Type Market 2023-2030 (Volume/Units)
4.Global Neopentylamine Market Analysis and Forecast by Type and Application Market 2023-2030 (Volume/Units)
5.North America Neopentylamine Market, by Type Market 2023-2030 ($M)
6.North America Neopentylamine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
7.South America Neopentylamine Market, by Type Market 2023-2030 ($M)
8.South America Neopentylamine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
9.Europe Neopentylamine Market, by Type Market 2023-2030 ($M)
10.Europe Neopentylamine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
11.APAC Neopentylamine Market, by Type Market 2023-2030 ($M)
12.APAC Neopentylamine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
13.MENA Neopentylamine Market, by Type Market 2023-2030 ($M)
14.MENA Neopentylamine Market Analysis and Forecast by Type and Application Market 2023-2030 ($M)
LIST OF FIGURES
1.US Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)2.Canada Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
3.Mexico Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
4.Brazil Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
5.Argentina Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
6.Peru Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
7.Colombia Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
8.Chile Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
9.Rest of South America Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
10.UK Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
11.Germany Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
12.France Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
13.Italy Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
14.Spain Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
15.Rest of Europe Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
16.China Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
17.India Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
18.Japan Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
19.South Korea Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
20.South Africa Global Neopentylamine Industry Market Revenue, 2023-2030 ($M)
21.North America Global Neopentylamine Industry By Application
22.South America Global Neopentylamine Industry By Application
23.Europe Global Neopentylamine Industry By Application
24.APAC Global Neopentylamine Industry By Application
25.MENA Global Neopentylamine Industry By Application